Angiosarcoma — Trials

Angiosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 10
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04607200	AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma	withdrawn	Phase 2	0	Agenus Inc.INDUSTRY	0	Jan 11, 2022	clinicaltrials
NCT05116800	Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma	withdrawn	Phase 2	0	Brown UniversityOTHER	1	Dec 7, 2021	clinicaltrials
NCT04906876